NeueHealth/$NEUE
About NeueHealth
Ticker
Trading on
Industry
Employees
NeueHealth Metrics
$61M
-
-$50.65
0.79
-
Price and volume
Market cap
$61M
Beta
0.79
52-week high
$11.35
52-week low
$3.79
Average daily volume
23K
Financial strength
Current ratio
0.676
Quick ratio
0.485
Long term debt to equity
-43.795
Total debt to equity
-43.795
Interest coverage (TTM)
-4.74%
Management effectiveness
Return on assets (TTM)
-5.10%
Return on equity (TTM)
207.62%
Valuation
Price to revenue (TTM)
0.06
Price to book
-0.05
Price to tangible book (TTM)
-0.04
Price to free cash flow (TTM)
-0.139
Growth
Revenue change (TTM)
-9.01%
Earnings per share change (TTM)
-75.50%
3-year revenue growth (CAGR)
-33.74%
3-year earnings per share growth (CAGR)
-31.73%
What the Analysts think about NeueHealth
Analyst Ratings
NeueHealth Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
NeueHealth Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
NeueHealth News

Bronstein, Gewirtz & Grossman, LLC Is Investigating NeueHealth, Inc. (NEUE) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against NeueHealth, Inc. (NEUE) and Encourages Shareholders to Learn More About the Investigation

The Schall Law Firm Invites Investors With Losses To Join An Investigation Into NeueHealth, Inc. For Securities Fraud
What’s the current market cap for NeueHealth stock?
What is the P/E ratio for NeueHealth stock?
Does NeueHealth stock pay dividends?
No, NeueHealth (NEUE) stock does not pay dividends to its shareholders as of February 22, 2025.
When is the next NeueHealth dividend payment date?
NeueHealth (NEUE) stock does not pay dividends to its shareholders.
What is the beta indicator for NeueHealth?
NeueHealth (NEUE) has a beta rating of 0.79. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.